Evidence map›Paper›PMID 15123841›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2004

Requirement for a conserved Toll/interleukin-1 resistance domain protein in the Caenorhabditis elegans immune response.

Nicole T Liberati, Katherine A Fitzgerald, Dennis H Kim, Rhonda Feinbaum, Douglas T Golenbock, Frederick M Ausubel

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 125 papers.

0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

125 citing papers in PubMed, 251 citations in OpenAlex.

  1. bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Use ofBiomolecules · 2024
    Review
  16. Article
  17. Article
  18. SARM1-Dependent Axon Degeneration: Nucleotide Signaling, Neurodegenerative Disorders, Toxicity, and Therapeutic Opportunities.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2024
    Review
  19. Article
  20. Article

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Nicole T LiberatiDepartment of Genetics, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA.
Katherine A Fitzgerald
Dennis H Kim
Rhonda Feinbaum
Douglas T Golenbock
Frederick M Ausubel
Harvard University · USUniversity of Massachusetts Chan Medical School · USMassachusetts General Hospital · US

Funding

Genetic Analysis of the Plant Defense ResponseR37GM048707 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI AUSUBEL, FREDERICK M · 2005 to 2014
$5.5M
Group B. Streptococci and Toll-like ReceptorsR01AI052455 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GOLENBOCK, DOUGLAS T · 2002 to 2012
$4.2M
GENETIC ANALYSIS OF THE PLANT DEFENSE RESPONSER01GM048707 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI AUSUBEL, FREDERICK M · 1993 to 2004
$1.9M
Group B. Streptococci and Toll-like ReceptorsR56AI052455 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GOLENBOCK, DOUGLAS T. · 2007 to 2007
$187k
NIAID NIH HHS AI52455NIAID NIH HHS R01 AI052455NIAID NIH HHS R56 AI052455NIGMS NIH HHS GM48707NIGMS NIH HHS R01 GM048707NIGMS NIH HHS R37 GM048707Wellcome Trust
6 · The paper itself

Abstract

The p38 mitogen-activated protein kinase pathway regulates innate immune responses in evolutionarily diverse species. We have previously shown that the Caenorhabditis elegans p38 mitogen-activated protein kinase, PMK-1, functions in an innate immune response pathway that mediates resistance to a variety of microbial pathogens. Here, we show that tir-1, a gene encoding a highly conserved Toll/IL-1 resistance (TIR) domain protein, is also required for C. elegans resistance to microbial pathogens. RNA interference inactivation of tir-1 resulted in enhanced susceptibility to killing by pathogens and correspondingly diminished PMK-1 phosphorylation. Unlike all known TIR-domain adapter proteins, overexpression of the human TIR-1 homologue, SARM, in mammalian cells was not sufficient to induce expression of NF-kappaB or IRF3-dependent reporter genes that are activated by Toll-like receptor signaling. These data reveal the involvement of a previously uncharacterized, evolutionarily conserved TIR domain protein in innate immunity that is functionally distinct from other known TIR domain signaling adapters.

Indexed as

AnimalsBase SequenceCaenorhabditis elegansDNA PrimersEnzyme ActivationGene Expression RegulationMembrane GlycoproteinsMitogen-Activated Protein Kinasesp38 Mitogen-Activated Protein KinasesReceptors, Interleukin-1Signal TransductionDNA PrimersMembrane GlycoproteinsMitogen-Activated Protein Kinasesp38 Mitogen-Activated Protein KinasesReceptors, Interleukin-1

Identifiers

PMID15123841
PMCPMC404090
OpenAlexW2008677145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.